CD4 and hepatocellular carcinoma: Moreover, between PWH with CD4+ lymphocyte count above or below 200/mm3 no significant differences were observed in CPT class (CPT A 71% vs. 66%, respectively, p = 0.92) and HCC stage at diagnosis (BCLC 0/A 55% vs. 58%; BCLC B 11% vs. 14%; BCLC C 22% vs. 14%; BCLC D 13% vs. 14% respectively, p = 0.19).